SCN2A

The SCN2A Foundation is dedicated to accelerating targeted research and treatment for the SCN2A disease - a disease at the intersection of untreatable epilepsy, autism, and other physical presentations, through strategic, cutting edge technologies and processes... SCN2A is one of the most common causes of neurodevelopmental disease and occurs in people of all ages and genders. In the US, current estimates are between 240 - 360 new cases per year - with these numbers expected to grow as genetic testing becomes more prevalent once targeted towards the autistic communities... Our goal is to accelerate targeted research that's specific to therapeutic development for SCN2A, and to improve survival and its debilitating symptoms.

Also known as: SCN2A Foundation

Primary location: Allison Park United States